COVID–19 eliminating PPE

Virucidal, Antiviral & Antimicrobial PPE that starts eliminating SARS-CoV-2, other viruses, and bacteria within minutes of contact*

Buy Now
Hero Image

Packing a punch

PPE that fights back

A subsidiary of ViraCorp, ViraCoat has developed a novel Virucidal, Antiviral & Antimicrobial Coating which has been demonstrated to have profound antiviral properties against SARS-CoV-2 (including new strains), Influenza (PR8 strain), and Bacteria (E. coli).

This proprietary Coating can be applied to and incorporated into PPE and other products to inactivate the virus and help to reduce the spread of COVID-19 and other infectious diseases.

Download a Brochure

View our Products
Through extensive research and development, ViraCoat is redefining the PPE space through innovative, next-generation technologies and products.


Research-backed innovations

Through partnership with world-leading experts at one of the UK’s most prestigious universities, all of our products have undergone thorough testing in both clinical and real-world environments.

Using live strains of virus within a Containment Level 3 laboratory, ViraCoat products have achieved all required certifications in addition to certifications which demonstrate proof of profound antiviral capabilities.

All masks are manufactured within a facility that is compliant with Module D of the Personal Protective Equipment (PPE) Regulation (EU) 2016/425.

Our manufacturing facility is under surveillance of both an EU Notified Body & a UK approved body that allows the product to be marked both CE & UKCA.

  • EN 149:2001 + A1 2009 FFP2
  • CE 0598
  • UKCA 0120
  • ISO 18184:2019 (Textiles – determination of antiviral activity in textile products)
  • ISO 10993-1:2018 (Biological evaluation of medical devices (safety, cytotoxicity, dermal & skin sensitisation))
ViraCoat aims to provide safer, more durable products where they are needed most, without the premium price tag.

A multi-faceted approach to protecting the world’s health

ViraCoat is part of ViraCorp

ViraCorp through its subsidiaries are a group of biomedical research and development companies, on a mission to improve the health outcomes for as many of the world’s population as possible.

Specifically focusing on protecting and preventing the disastrous humanitarian and economic impacts of viral outbreaks, pandemics and endemic infections, ViraCorp is taking an innovative, disruptive approach to developing viral defence products.

ViraCorp has a formidable combination of unique Intellectual Property, world-class researchers and facilities, and a multidisciplinary, seasoned management team that uniquely position it for success.

Find out more about ViraCorp

Contact Us

Expression of Interest

Contact Form Image

    I am making a general enquiry.I would like to become a distributor.